BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19043076)

  • 1. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
    Grozav AG; Chikamori K; Kozuki T; Grabowski DR; Bukowski RM; Willard B; Kinter M; Andersen AH; Ganapathi R; Ganapathi MK
    Nucleic Acids Res; 2009 Feb; 37(2):382-92. PubMed ID: 19043076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.
    Chikamori K; Grabowski DR; Kinter M; Willard BB; Yadav S; Aebersold RH; Bukowski RM; Hickson ID; Andersen AH; Ganapathi R; Ganapathi MK
    J Biol Chem; 2003 Apr; 278(15):12696-702. PubMed ID: 12569090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
    Aoyama M; Grabowski DR; Dubyak GR; Constantinou AI; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):727-33. PubMed ID: 9841887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
    Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
    Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein kinase II stabilizes the activity of human topoisomerase IIalpha in a phosphorylation-independent manner.
    Redwood C; Davies SL; Wells NJ; Fry AM; Hickson ID
    J Biol Chem; 1998 Feb; 273(6):3635-42. PubMed ID: 9452492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
    Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
    Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
    Chresta CM; Hall BF; Francis GE
    Leukemia; 1995 Aug; 9(8):1373-81. PubMed ID: 7643627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UPR-induced resistance to etoposide is downstream of PERK and independent of changes in topoisomerase IIα levels.
    Mann MJ; Pereira ER; Liao N; Hendershot LM
    PLoS One; 2012; 7(10):e47931. PubMed ID: 23144714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposide.
    Grabowski DR; Holmes KA; Aoyama M; Ye Y; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
    Mol Pharmacol; 1999 Dec; 56(6):1340-5. PubMed ID: 10570063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yck1 casein kinase I regulates the activity and phosphorylation of Pah1 phosphatidate phosphatase from
    Hassaninasab A; Hsieh LS; Su WM; Han GS; Carman GM
    J Biol Chem; 2019 Nov; 294(48):18256-18268. PubMed ID: 31645435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast.
    Nakazawa N; Arakawa O; Ebe M; Yanagida M
    J Biol Chem; 2019 Mar; 294(10):3772-3782. PubMed ID: 30635402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential roles of CKIdelta and CKIepsilon in the mammalian circadian clock.
    Lee H; Chen R; Lee Y; Yoo S; Lee C
    Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21359-64. PubMed ID: 19948962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex.
    Pitts SL; Jablonksy MJ; Duca M; Dauzonne D; Monneret C; Arimondo PB; Anklin C; Graves DE; Osheroff N
    Biochemistry; 2011 Jun; 50(22):5058-66. PubMed ID: 21548574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.
    Smal C; Vertommen D; Amsailale R; Arts A; Degand H; Morsomme P; Rider MH; Neste EV; Bontemps F
    Arch Biochem Biophys; 2010 Oct; 502(1):44-52. PubMed ID: 20637175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
    Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
    Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase IIalpha controls the decatenation checkpoint.
    Luo K; Yuan J; Chen J; Lou Z
    Nat Cell Biol; 2009 Feb; 11(2):204-10. PubMed ID: 19098900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta.
    Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES
    Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylate, a catalytic inhibitor of topoisomerase II, inhibits DNA cleavage and is selective for the α isoform.
    Bau JT; Kang Z; Austin CA; Kurz EU
    Mol Pharmacol; 2014 Feb; 85(2):198-207. PubMed ID: 24220011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.